Company Active LTD

Company profile

Fourth State Medicine Ltd

Air Plasma Ozone & NOx Generators - Fourth State

Making the biochemical benefits of Reactive Oxygen and Nitrogen Species (RONS) accessible, anywhere, anytime - with just air and electricity.

CRN
08335942
Founded
2012
Age
13

Overview

Legal name
FOURTH STATE MEDICINE LTD
Region
South East England
Registered address
Unknown
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

2 events
15 Nov
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ0MzU1OTU5MmFkaXF6a2N4

Published 15 Nov 2024 12:16

19 Dec
2012

Incorporated

Inception

Company registered at Companies House

Public funding

5 awards
First funded
2014
Funded years
2014, 2018, 2020, 2022, 2024
Age at first award
1 years

Projects

2024 Collaborative R&D Lead participant

Gas measurement for air plasma generators

1 Feb 2024 to 30 Jun 2024

Awarded
£11,049
Total cost £18,415

Plasma, ionised gas, is the fourth state of matter after solid, liquid and gas. The sun, the aurora and lightning are all natural examples, while plasma technologies include advanced silicon etching machines, space propulsion systems and nuclear fusion reactors. Atmospheric pressure plasma technologies can be used for chemical synthesis - scrambling molec...

2022 Collaborative R&D Lead participant

Measuring the complex air-plasma chemistries of ModuNOxD; an antiviral Ozone/NOx treatment for public transport and infrastructure.

1 Jan 2022 to 31 Mar 2022

Awarded
£8,534
Total cost £8,534

Fourth State makes products which generate useful reactive gases by combining ambient air and electricity; we specialise in generating oxides of nitrogen and ozone in-situ. Our technology is based on plasma (ionised gas), the fourth state of matter after solid, liquid and gas. This A4I feasibility project with The National Physical Laboratory will seek to...

2020 Feasibility Studies Lead participant

Nitric Oxide (NO) inhalation to treat COVID-19: coupling in-situ NO-generating modules to ventilators

1 Aug 2020 to 31 Mar 2021

Awarded
£49,576
Total cost £49,576

**COVID-19:** in December 2019, the Wuhan Municipal Health Committee identified an outbreak of viral pneumonia of unknown cause. Coronavirus RNA was quickly identified in some of these patients. This novel coronavirus has been designated SARS-CoV-2, and the disease caused by this virus defined as COVID-19\. This disease has now become pandemic, and with w...

2018 Feasibility Studies Lead participant

Development and application of a new technology for the targeted management of biofilms in human chronic wounds

1 Nov 2018 to 31 Jan 2020

Awarded
£49,000
Total cost £70,000

"Wounds to the skin normally heal quickly and efficiently, but this is not always the case. In fact, across Europe over 80 million people are currently suffering with a range of wounds that fail to heal. These chronic wounds can remain unhealed for many years, significantly decreasing quality of life and increasing the chance of developing major complicat...

2014 Vouchers Lead participant

4SM Halo product dev. voucher application

1 Aug 2014 to 31 Jan 2015

Awarded
£5,000
Total cost £5,000

Fourth State Medicine has developed a novel plasma energy delivery system for the purposes of wrinkle removal in cosmetic surgery and wound care. With a large consortium covering the disciplines of medicine, engineering, distribution and research they aim to change the state of medicine through this innovative platform technology.

Product types

Collaborative R&D Feasibility Studies Vouchers